Global Hepatitis A Vaccine Competitive Landscape Professional Research Report 2024

Global Hepatitis A Vaccine Competitive Landscape Professional Research Report 2024



Research Summary

The Hepatitis A vaccine is a preventive immunization designed to protect individuals against the Hepatitis A virus, which causes a contagious liver infection. The vaccine stimulates the immune system to produce antibodies that provide immunity against the virus. Hepatitis A is typically transmitted through contaminated food or water and can lead to symptoms such as fever, fatigue, abdominal pain, and jaundice. The Hepatitis A vaccine is administered through a series of two shots, with the second dose given six to twelve months after the initial vaccination. Vaccination is recommended for individuals at higher risk of exposure, such as travelers to regions with high Hepatitis A prevalence, certain healthcare workers, and individuals with chronic liver diseases. The vaccine has proven effective in preventing Hepatitis A infections, contributing to public health efforts to control the spread of the virus.

According to DIResearch's in-depth investigation and research, the global Hepatitis A Vaccine market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Hepatitis A Vaccine include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, IMBCAMS, KM Biologics, Convac etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Hepatitis A Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Hepatitis A Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Hepatitis A Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Hepatitis A Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Hepatitis A Vaccine Include:

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

IMBCAMS

KM Biologics

Convac

Hepatitis A Vaccine Product Segment Include:

Inactivated Vaccine

Live Attenuated Vaccine

Hepatitis A Vaccine Product Application Include:

Government Institution

Private Sector

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Hepatitis A Vaccine Industry PESTEL Analysis

Chapter 3: Global Hepatitis A Vaccine Industry Porter’s Five Forces Analysis

Chapter 4: Global Hepatitis A Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Hepatitis A Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Hepatitis A Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Hepatitis A Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Hepatitis A Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Hepatitis A Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Hepatitis A Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Hepatitis A Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Hepatitis A Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Hepatitis A Vaccine Market Overview
1.1 Product Definition and Statistical Scope
1.2 Hepatitis A Vaccine Product by Type
1.2.1 Global Hepatitis A Vaccine Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Hepatitis A Vaccine Product by Application
1.3.1 Global Hepatitis A Vaccine Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A Vaccine Market Revenue and Sales Analysis
1.4.1 Global Hepatitis A Vaccine Market Size Analysis (2019-2030)
1.4.2 Global Hepatitis A Vaccine Market Sales Analysis (2019-2030)
1.4.3 Global Hepatitis A Vaccine Market Sales Price Trend Analysis (2019-2030)
1.5 Hepatitis A Vaccine Market Development Status and Trends
1.5.1 Hepatitis A Vaccine Industry Development Status Analysis
1.5.2 Hepatitis A Vaccine Industry Development Trends Analysis
2 Hepatitis A Vaccine Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Hepatitis A Vaccine Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Hepatitis A Vaccine Market Analysis by Regions
4.1 Hepatitis A Vaccine Overall Market: 2023 VS 2024 VS 2030
4.2 Global Hepatitis A Vaccine Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Hepatitis A Vaccine Revenue and Market Share by Region (2019-2024)
4.2.2 Global Hepatitis A Vaccine Revenue Forecast by Region (2025-2030)
4.3 Global Hepatitis A Vaccine Sales and Forecast Analysis (2019-2030)
4.3.1 Global Hepatitis A Vaccine Sales and Market Share by Region (2019-2024)
4.3.2 Global Hepatitis A Vaccine Sales Forecast by Region (2025-2030)
4.4 Global Hepatitis A Vaccine Sales Price Trend Analysis (2019-2030)
5 Global Hepatitis A Vaccine Market Size by Type and Application
5.1 Global Hepatitis A Vaccine Market Size by Type
5.1.1 Global Hepatitis A Vaccine Revenue and Forecast Analysis by Type (2019-2030)
5.1.2 Global Hepatitis A Vaccine Sales and Forecast Analysis by Type (2019-2030)
5.2 Global Hepatitis A Vaccine Market Size by Application
5.2.1 Global Hepatitis A Vaccine Revenue and Forecast Analysis by Application (2019-2030)
5.2.2 Global Hepatitis A Vaccine Sales and Forecast Analysis by Application (2019-2030)
6 North America
6.1 North America Hepatitis A Vaccine Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Hepatitis A Vaccine Market Size by Type
6.3.1 North America Hepatitis A Vaccine Sales by Type (2019-2030)
6.3.2 North America Hepatitis A Vaccine Revenue by Type (2019-2030)
6.4 North America Hepatitis A Vaccine Market Size by Application
6.4.1 North America Hepatitis A Vaccine Sales by Application (2019-2030)
6.4.2 North America Hepatitis A Vaccine Revenue by Application (2019-2030)
6.5 North America Hepatitis A Vaccine Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Hepatitis A Vaccine Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Hepatitis A Vaccine Market Size by Type
7.3.1 Europe Hepatitis A Vaccine Sales by Type (2019-2030)
7.3.2 Europe Hepatitis A Vaccine Revenue by Type (2019-2030)
7.4 Europe Hepatitis A Vaccine Market Size by Application
7.4.1 Europe Hepatitis A Vaccine Sales by Application (2019-2030)
7.4.2  Europe Hepatitis A Vaccine Revenue by Application (2019-2030)
7.5 Europe Hepatitis A Vaccine Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Hepatitis A Vaccine Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Hepatitis A Vaccine Market Size by Type
8.3.1 China Hepatitis A Vaccine Sales by Type (2019-2030)
8.3.2 China Hepatitis A Vaccine Revenue by Type (2019-2030)
8.4 China Hepatitis A Vaccine Market Size by Application
8.4.1 China Hepatitis A Vaccine Sales by Application (2019-2030)
8.4.2 China Hepatitis A Vaccine Revenue by Application (2019-2030)
9 APAC (excl. China)
9.1 APAC (excl. China) Hepatitis A Vaccine Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Hepatitis A Vaccine Market Size by Type
9.3.1 APAC (excl. China) Hepatitis A Vaccine Sales by Type (2019-2030)
9.3.2 APAC (excl. China) Hepatitis A Vaccine Revenue by Type (2019-2030)
9.4 APAC (excl. China) Hepatitis A Vaccine Market Size by Application
9.4.1 APAC (excl. China) Hepatitis A Vaccine Sales by Application (2019-2030)
9.4.2 APAC (excl. China) Hepatitis A Vaccine Revenue by Application (2019-2030)
9.5 APAC (excl. China) Hepatitis A Vaccine Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Hepatitis A Vaccine Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Hepatitis A Vaccine Market Size by Type
10.3.1 Latin America Hepatitis A Vaccine Sales by Type (2019-2030)
10.3.2 Latin America Hepatitis A Vaccine Revenue by Type (2019-2030)
10.4 Latin America Hepatitis A Vaccine Market Size by Application
10.4.1 Latin America Hepatitis A Vaccine Sales by Application (2019-2030)
10.4.2 Latin America Hepatitis A Vaccine Revenue by Application (2019-2030)
10.5 Latin America Hepatitis A Vaccine Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Hepatitis A Vaccine Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Hepatitis A Vaccine Market Size by Type
11.3.1 Middle East & Africa Hepatitis A Vaccine Sales by Type (2019-2030)
11.3.2 Middle East & Africa Hepatitis A Vaccine Revenue by Type (2019-2030)
11.4 Middle East & Africa Hepatitis A Vaccine Market Size by Application
11.4.1 Middle East & Africa Hepatitis A Vaccine Sales by Application (2019-2030)
11.4.2 Middle East & Africa Hepatitis A Vaccine Revenue by Application (2019-2030)
11.5 Middle East & Africa Hepatitis A Vaccine Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Hepatitis A Vaccine Market Sales, Revenue and Price by Key Manufacturers (2020-2024)
12.1.1 Global Hepatitis A Vaccine Market Sales by Key Manufacturers (2020-2024)
12.1.2 Global Hepatitis A Vaccine Market Revenue by Key Manufacturers (2020-2024)
12.1.3 Global Hepatitis A Vaccine Average Sales Price by Manufacturers (2020-2024)
12.2 Hepatitis A Vaccine Competitive Landscape Analysis and Market Dynamic
12.2.1 Hepatitis A Vaccine Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 GSK
13.1.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 GSK Hepatitis A Vaccine Product Portfolio
13.1.3 GSK Hepatitis A Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.2 Merck
13.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Merck Hepatitis A Vaccine Product Portfolio
13.2.3 Merck Hepatitis A Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.3 Sanofi
13.3.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Sanofi Hepatitis A Vaccine Product Portfolio
13.3.3 Sanofi Hepatitis A Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.4 Sinovac
13.4.1 Sinovac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Sinovac Hepatitis A Vaccine Product Portfolio
13.4.3 Sinovac Hepatitis A Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
13.5.3 Zhejiang Pukang Hepatitis A Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
13.6.3 Changchun Institute of Biological Hepatitis A Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.7 IMBCAMS
13.7.1 IMBCAMS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 IMBCAMS Hepatitis A Vaccine Product Portfolio
13.7.3 IMBCAMS Hepatitis A Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.8 KM Biologics
13.8.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 KM Biologics Hepatitis A Vaccine Product Portfolio
13.8.3 KM Biologics Hepatitis A Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.9 Convac
13.9.1 Convac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Convac Hepatitis A Vaccine Product Portfolio
13.9.3 Convac Hepatitis A Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Hepatitis A Vaccine Industry Chain Analysis
14.2 Hepatitis A Vaccine Industry Upstream Supply Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Hepatitis A Vaccine Typical Downstream Customers
14.4 Hepatitis A Vaccine Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings